Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
110.13
-1.28 (-1.15%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Novartis AG Revenue
In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth. Novartis AG had revenue of $13.56B in the quarter ending December 31, 2024, with 15.13% growth.
Revenue (ttm)
$51.72B
Revenue Growth
+10.85%
P/S Ratio
4.09
Revenue / Employee
$681,602
Employees
75,883
Market Cap
211.63B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
| Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
| Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
| Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
| Dec 31, 2020 | 49.90B | 1.22B | 2.51% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
| Abbott Laboratories | 42.34B |
NVS News
- 13 hours ago - Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs - Reuters
- 2 days ago - LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed - FXEmpire
- 9 days ago - Trump says US pharma tariffs coming in not-too-distant future - Reuters
- 12 days ago - Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages - CNBC
- 12 days ago - Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs - Investopedia
- 13 days ago - Novartis plans to invest $23 billion in US plants as Trump renews drug tariff threats - Reuters
- 13 days ago - Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback - CNBC
- 14 days ago - Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out - Seeking Alpha